Supplemental Schedule of Noncash Financing Activities (Details) - USD ($)		12 Months Ended
	May 04, 2012	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jan. 27, 2014
Other Significant Noncash Transactions [Line Items]
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested, Shares		17,185
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested		$ (998,000)	$ (2,202,000)	$ (41,000)
Common Stock Repurchase not settled, Shares		109,475	25,000
Common Stock Repurchase not settled, Value		$ 6,400,000	$ 820,000
Derivative Liability		8,510,000	4,277,000	$ 5,367,000
Curepet, Inc.
Other Significant Noncash Transactions [Line Items]
Purchase Price of Business Acquisition, Cost of Acquired Entity					$ 6,350,000
Derivative Liability		$ 0	$ 0		5,000,000
Cash consideration offset against open receivable balances due to Ebix, Inc. from CurePet					$ 1,350,000
Cost Method Investment, Ownership Percentage	19.80%
Payments to acquire cost method investment	$ 2,000,000